Threshold Analysis and Programs for Prevention of HIV Infection
- 1 October 1995
- journal article
- research article
- Published by SAGE Publications in Medical Decision Making
- Vol. 15 (4) , 311-317
- https://doi.org/10.1177/0272989x9501500402
Abstract
Background. Measuring the economic effectiveness of HIV-infection prevention activities poses special challenges in terms of behavioral change and health outcomes assessment. Methods. One way to address this difficulty is to employ threshold analysis to determine a level of cost per HIV infection averted above which society would seem unwilling to pay. The authors employ a cost-utility analytic framework to determine a monetary threshold for HIV prevention programs, subject base-case results to sensitivity analyses, and apply these results to the Centers for Disease Control and Prevention's fiscal year 1993 budget for extramural HIV prevention programs. Results. The monetary threshold for cost per HIV infection averted was calculated to be $417,000 in 1993 dollars, and ranged from $185,000 to $648,000 depending upon the dollar amount society would be willing to pay per quality- adjusted life year gained. Conclusions. Economic evaluations of particular HIV-infection prevention activities at least can begin by determining whether their levels of effectiveness are above or below this derived monetary threshold, and refinements beyond this dichoto mous evaluation can proceed as further data become available. Key words: HIV; AIDS; prevention; threshold analysis; cost-utility analysis. (Med Decis Making 1995;15:311-317)Keywords
This publication has 18 references indexed in Scilit:
- Declining Age at HIV Infection in the United StatesNew England Journal of Medicine, 1994
- Changing incidence of Pneumocystis carinii pneumonia as initial AIDS defining disease in the United KingdomAIDS, 1993
- Health-Related Quality of Life in Persons with Acquired Immune Deficiency SyndromeMedical Care, 1993
- Longitudinal study on the Quality of Life of symptomatic HIV-infected patients in a trial of zidovudine versus zidovudine and interferon-aAIDS, 1993
- Describing the health-related quality of life impact of HIV infection: Findings from a study using the HIV Overview of Problems?Evaluation System (HOPES)Quality of Life Research, 1993
- Differences in Mortality Rates and Causes of Death between HIV Positive and HIV Negative Intravenous Drug UsersInternational Journal of Epidemiology, 1993
- An economic evaluation of home-care assistance for AIDS patientsAIDS, 1992
- AIDS and Absolutism — The Demand for Perfection in PreventionNew England Journal of Medicine, 1992
- Prognostic factors and survival in children with perinatal HIV-1 infectionThe Lancet, 1992
- The Quality of Well-Being ScaleMedical Care, 1989